Epstein Secrets

alue which will benefit both stakeholders and shareholders of GP's portfolio companies. • GP's primary focus is on US-listed companies which are in the Tech/Telcom, Natural Resources, Consumer Retail, Healthcare Services and Business Services sectors. GP's target return is 2-5x on invested capital over a 2-4 y

/31/201 2 2 365 194 GH (Pro Forma) 12/31/2013 500-1.000 0-5% 100-2(41 50-100 TBD TBD 'FBI) TBD GH figures Pro Forma consolidation of Target Company "A" and US$50 million Pref. issuance SMIRC CMIC ond company repons. Market share price daa as of 9.27'201? EFTA_R1_01947061 EFTA02672845

alue which will benefit both stakeholders and shareholders of GP's portfolio companies. • GP's primary focus is on US-listed companies which are in the Tech/Telcom, Natural Resources, Consumer Retail, Healthcare Services and Business Services sectors. GP's target return is 2-5x on invested capital over a 2-4 y

4x 0.5 .1 \ Div/Yield Institutional 66.4% 59.8% 85.4% 28.8% 1.0% 10.2% I TBD Ownership 0.9% 4.7% GI figures Pro Forma consolidation of Target Company "A" and US$5O million Pref. issuance Source: CNI3C and company reports. Market share price data as 0(9.27,2013 EFTA00505806

alue which will benefit both stakeholders and shareholders of GP's portfolio companies. • GP's primary focus is on US-listed companies which are in the Tech/Telcom, Natural Resources, Consumer Retail, Healthcare Services and Business Services sectors. GP's target return is 2-5x on invested capital over a 2-4 y

1/2012 12/31/2013 E 497 500-1,000 4.6% 0-5% 1,414 365 194 100-200 50-100 TBD TBD TBD 10.2% TBD GH figures Pro Forma consolidation of Target Company "A" and US$5O million Pref issuance Source: CNI3C and company reports. Market share price data as of 9/2712013 31 EFTA00505837